Premix Vancomycin Injection in Sodium Chloride Launched


Baxter International Inc has launched a ready-to-use version of Vancomycin injection.

Baxter International Inc has launched a ready-to-use version of Vancomycin injection.

The product, which treats infections caused by susceptible strains of methicillin-resistant staphylococci, comes in 0.9% sodium chloride in 500 mg, 750 mg, and 1 gram presentations.

“As a company whose mission is focused on saving and sustaining lives, Baxter’s launch of Vancomycin injection as an innovative premixed saline presentation provides new options of an important antibiotic to address patient needs and demonstrates our commitment to making premixed preparations of medications more efficient for health care practitioners,” said Brik Eyre, president of Baxter’s Hospital Products business, in a press release.

Baxter is currently the only manufacturer to offer the antibiotic in a premixed presentation.

The launch of this product is an extension of Baxter’s existing line of Vancomycin injection in 5% dextrose (available in 500 mg, 750 mg and 1 gram presentations). The new alternative can be useful for patients who may need to avoid additional dextrose.

Baxter’s premix technology is designed for unstable molecules that are often administered using standard doses.

Related Videos
Pride flags during pride event -- Image credit: ink drop |
Female Pharmacist Holding Tablet PC - Image credit: Tyler Olson |
African American male pharmacist using digital tablet during inventory in pharmacy - Image credit: sofiko14 |
Young woman using smart phone,Social media concept. - Image credit: Urupong |
selling mental health medication to man at pharmacy | Image Credit: Syda Productions -
Medicine tablets on counting tray with counting spatula at pharmacy | Image Credit: sutlafk -
Concept of health care, pharmaceutical business, drug prices, pharmacy, medicine and economics | Image Credit: Oleg -
Image credit: |
© 2024 MJH Life Sciences

All rights reserved.